These results suggested that the decline in GLT-1 uptake activity is involved in the cognitive impairment of AD mice, and Cef may alleviate cognitive impairment by improving the activity of GLT-1 uptake. This evidence concerns the gene SLC1A2 and Alzheimer disease.